Ricochet is the best place on the internet to discuss the issues of the day, either through commenting on posts or writing your own for our active and dynamic community in a fully moderated environment. In addition, the Ricochet Audio Network offers over 50 original podcasts with new episodes released every day.
Member Post
A group of oncologists estimate that 60,000 people in the UK will die of cancer because they were unable to get adequate treatment due to COVID-19 restrictions. I am torn about what to think about this estimate. Why should one trust the prognostications of a group of oncologists any more than one trusts the prognostications […]
This is a members-only post on Ricochet's Member Feed. Want to read it? Join Ricochet’s community of conservatives and be part of the conversation. Get your first month free.
One of the oddest and most fascinating debates about this whole COVID thing is the battle of studies over the 60-year-old anti-malaria drug, Hydroxychloriquine (treatment often also includes Zythromax, a commonly-used, broad-spectrum anti-biotic, and Zinc supplements) being used “off label.” Its use for such off-label purposes has been approved by the Food and Drug Administration (FDA).
Our veterans are dying in increasing numbers—at their own hands. I was moved to explore this topic thanks to Nicole Fisher of The Federalist’s 
